4552 — JCR Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥99bn
- ¥105bn
- ¥34bn
- 70
- 49
- 36
- 51
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,497 | 11,193 | 26,260 | 30,977 | 13,278 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,835 | 7,977 | 8,183 | 15,585 | 11,137 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 27,368 | 28,342 | 48,545 | 62,188 | 47,802 |
Net Property, Plant And Equipment | 11,061 | 14,875 | 17,172 | 26,782 | 32,681 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 42,516 | 47,775 | 73,784 | 97,134 | 94,937 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,684 | 10,434 | 29,028 | 42,054 | 35,762 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,831 | 15,385 | 35,401 | 46,250 | 42,775 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 30,685 | 32,390 | 38,383 | 50,884 | 52,162 |
Total Liabilities & Shareholders' Equity | 42,516 | 47,775 | 73,784 | 97,134 | 94,937 |
Total Common Shares Outstanding |